Home › 503B register › Annovex Pharma, Inc.
FDA register as of 2026-09-02
Annovex Pharma, Inc.
Annovex Pharma, Inc., Lorton, VA, is registered with the FDA as a 503B outsourcing facility (first registered 10/14/2021; most recent registration 2/13/2026). The FDA last inspected it on 6/3/2026; a Form 483 was issued, a recall was not conducted, and the action recorded is “Open”.
- Status
- 503B REGISTERED
- Location
- Lorton, VA
- First registration
- 10/14/2021
- Most recent registration
- 2/13/2026
- Last FDA inspection
- 6/3/2026
- Form 483 issued
- Yes · read the 483
- Recall conducted
- No
- Action based on last inspection
- Open
- Compounds sterile drugs from bulk
- Yes
- Contact listed by the FDA
- Adedayo Akinbi · 1-571-642-5262
How to read this record
Registration means the facility has registered with the FDA under section 503B and is subject to FDA inspection under current good manufacturing practice. It is not an endorsement. A Form 483 is the list of observations an investigator leaves at the end of an inspection; it is not a finding of violation, and most inspected facilities on the register have received one. “Open” means the FDA has not finalised the inspection's classification. A regulatory meeting or a warning letter is a further step, and the FDA posts the letter, which we link when it does.
What this page does not tell you: whether a specific drug from this facility is right for you, or whether the telehealth brand that sold it to you is the same entity. Compounded prescriptions are labelled with the pharmacy that made them — compare that label to this name.
Source: FDA — Registered Outsourcing Facilities, as of 2026-09-02; every value above is the FDA's, reproduced without characterisation. Back to the full register, or look up another pharmacy.